Rating History for Halozyme Therapeutics (HALO) by Leerink Partners
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 10/14/2025 | David Risinger | Upgrade | Market Perform (Underperform) |
70.00 (N/A) |
65.33 (67.37) |
3.12% | Details |
 |
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
